| 1 |
34969747 | Excellent Response to MEK Inhibition in an AGK-BRAF Gene Fusion Driven Carcinoma: Case Report and Literature Review. | 2022 Jan |
1 |
| 2 |
34458148 | Tyrosine Kinase Inhibitors Stimulate HLA Class I Expression by Augmenting the IFNγ/STAT1 Signaling in Hepatocellular Carcinoma Cells. | 2021 |
5 |
| 3 |
34940128 | Effect of Regorafenib on P2X7 Receptor Expression and Different Oncogenic Signaling Pathways in a Human Breast Cancer Cell Line: A Potential of New Insight of the Antitumor Effects of Regorafenib. | 2021 Dec 9 |
1 |
| 4 |
32562663 | Sirt3 promotes hepatocellular carcinoma cells sensitivity to regorafenib through the acceleration of mitochondrial dysfunction. | 2020 Aug 15 |
1 |
| 5 |
30761258 | Regorafenib reverses HGF-induced sorafenib resistance by inhibiting epithelial-mesenchymal transition in hepatocellular carcinoma. | 2019 Feb |
1 |
| 6 |
30801954 | Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF-κB-modulated tumor progression in bladder cancer in vitro and in vivo. | 2019 Jun |
1 |
| 7 |
31163381 | Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo. | 2019 Aug |
1 |
| 8 |
31238539 | Protein Kinase B and Extracellular Signal-Regulated Kinase Inactivation is Associated with Regorafenib-Induced Inhibition of Osteosarcoma Progression In Vitro and In Vivo. | 2019 Jun 24 |
2 |
| 9 |
29359239 | The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myeloma. | 2018 May |
1 |
| 10 |
29423069 | Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option. | 2018 Jan 9 |
1 |
| 11 |
28000898 | Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-κB activation in hepatocellular carcinoma cells. | 2017 Feb |
6 |
| 12 |
29291014 | Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma. | 2017 Dec 5 |
1 |
| 13 |
29371921 | Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients. | 2017 Dec 26 |
1 |
| 14 |
26921392 | Addition of DHA Synergistically Enhances the Efficacy of Regorafenib for Kidney Cancer Therapy. | 2016 May |
1 |